This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
The American public’s trust in healthcare institutions, long a matter of common courtesy, fell off a cliff after the COVID-19 crisis. Two academic physicians propose a treatment pathway for the injured patient—aka our healthcare system’s reputation for reliability.
The Department of Health and Human Services has unfurled a roadmap for aligning its approach to AI adoption in healthcare with the broad AI aspirations of President Trump.
The popular SGLT2 inhibitor, sold under the brand name Farxiga, is approved by the FDA to treat heart failure, type 2 diabetes and CKD. Recent data on its ability to affect the symptoms of heart failure patients have been inconsistent.
In its annual outlook report released this week, Fitch Ratings says the coming calendar year will probably strike much of the sector as “another make or break” period.